Tempest Therapeutics (NASDAQ:TPST) Research Coverage Started at Jefferies Financial Group
Jefferies Financial Group initiated coverage on shares of Tempest Therapeutics (NASDAQ:TPST – Free Report) in a report released on Thursday morning, Briefing.com reports. The brokerage issued a buy rating and a $15.00 target price on the stock. Separately, HC Wainwright lifted their target price on shares of Tempest Therapeutics from $35.00 to $47.00 and gave […]
More Stories
Target Corporation (NYSE:TGT) Position Boosted by IFP Advisors Inc
IFP Advisors Inc grew its position in Target Corporation (NYSE:TGT – Free Report) by 233.6% in the 1st quarter, according...
Private Advisor Group LLC Has $4.30 Million Position in Newmont Corporation (NYSE:NEM)
Private Advisor Group LLC boosted its stake in Newmont Corporation (NYSE:NEM – Free Report) by 9.7% during the 1st quarter,...
Csenge Advisory Group Lowers Stock Holdings in Mondelez International, Inc. (NASDAQ:MDLZ)
Csenge Advisory Group reduced its stake in Mondelez International, Inc. (NASDAQ:MDLZ – Free Report) by 32.7% during the 1st quarter,...
Kestra Private Wealth Services LLC Buys 1,221 Shares of Canadian Pacific Kansas City Limited (NYSE:CP)
Kestra Private Wealth Services LLC boosted its holdings in Canadian Pacific Kansas City Limited (NYSE:CP – Free Report) (TSE:CP) by...
Csenge Advisory Group Sells 322 Shares of Boston Scientific Corporation (NYSE:BSX)
Csenge Advisory Group reduced its stake in Boston Scientific Corporation (NYSE:BSX – Free Report) by 10.5% in the 1st quarter,...
Csenge Advisory Group Makes New $221,000 Investment in Simon Property Group, Inc. (NYSE:SPG)
Csenge Advisory Group purchased a new position in shares of Simon Property Group, Inc. (NYSE:SPG – Free Report) during the...